These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17051491)

  • 1. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study.
    Lowe DO; Mamdani MM; Kopp A; Low DE; Juurlink DN
    Clin Infect Dis; 2006 Nov; 43(10):1272-6. PubMed ID: 17051491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors.
    Jayatilaka S; Shakov R; Eddi R; Bakaj G; Baddoura WJ; DeBari VA
    Ann Clin Lab Sci; 2007; 37(3):241-7. PubMed ID: 17709687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.
    Bajaj JS; Ananthakrishnan AN; Hafeezullah M; Zadvornova Y; Dye A; McGinley EL; Saeian K; Heuman D; Sanyal AJ; Hoffmann RG
    Am J Gastroenterol; 2010 Jan; 105(1):106-13. PubMed ID: 19844204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
    Kim YG; Graham DY; Jang BI
    J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.
    Pépin J; Saheb N; Coulombe MA; Alary ME; Corriveau MP; Authier S; Leblanc M; Rivard G; Bettez M; Primeau V; Nguyen M; Jacob CE; Lanthier L
    Clin Infect Dis; 2005 Nov; 41(9):1254-60. PubMed ID: 16206099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study.
    Tumbarello M; Tacconelli E; Leone F; Cauda R; Ortona L
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):259-63. PubMed ID: 7743309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of community-associated Clostridium difficile infection.
    Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
    J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile.
    Kazakova SV; Ware K; Baughman B; Bilukha O; Paradis A; Sears S; Thompson A; Jensen B; Wiggs L; Bessette J; Martin J; Clukey J; Gensheimer K; Killgore G; McDonald LC
    Arch Intern Med; 2006 Dec 11-25; 166(22):2518-24. PubMed ID: 17159019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
    Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
    Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
    Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
    Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.
    Choudhry MN; Soran H; Ziglam HM
    QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease.
    Dubberke ER; Reske KA; Olsen MA; McMullen KM; Mayfield JL; McDonald LC; Fraser VJ
    Arch Intern Med; 2007 May; 167(10):1092-7. PubMed ID: 17533213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea.
    Yearsley KA; Gilby LJ; Ramadas AV; Kubiak EM; Fone DL; Allison MC
    Aliment Pharmacol Ther; 2006 Aug; 24(4):613-9. PubMed ID: 16907893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.
    Dalton BR; Lye-Maccannell T; Henderson EA; Maccannell DR; Louie TJ
    Aliment Pharmacol Ther; 2009 Mar; 29(6):626-34. PubMed ID: 19183143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and appropriateness of empiric metronidazole for Clostridium difficile-associated diarrhea.
    Vasa CV; Glatt AE
    Am J Gastroenterol; 2003 Feb; 98(2):354-8. PubMed ID: 12591054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
    Lupse M; Flonta M; Cioara A; Filipescu I; Todor N
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):397-403. PubMed ID: 24369321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors.
    Dubberke ER; Reske KA; Yan Y; Olsen MA; McDonald LC; Fraser VJ
    Clin Infect Dis; 2007 Dec; 45(12):1543-9. PubMed ID: 18190314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile in cardiac surgery: risk factors and impact on postoperative outcome.
    Crabtree T; Aitchison D; Meyers BF; Tymkew H; Smith JR; Guthrie TJ; Munfakh N; Moon MR; Pasque MK; Lawton J; Moazami N; Damiano RJ
    Ann Thorac Surg; 2007 Apr; 83(4):1396-402. PubMed ID: 17383346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.